Brain Cancer Trial, Recruiting NCT02686229 Sponsor: University of Ulm Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT02686229
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have brain imaging results that suggest they may have a low grade glioma (a type of slow-growing brain tumour)
  • People who are 18 years of age or older (there is no upper age limit)

Who may not be able to join:

  • People who have a serious neurological or psychiatric condition that would prevent them from being able to give informed consent to participate
  • People who do not agree to have their personal disease information registered, stored, and processed, or do not agree to have their family doctor informed about their participation in the study
  • People who do not agree to have biological samples (such as blood or tissue) stored and used for research analysis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 082219628858

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Ulm
Registry
ClinicalTrials.gov
Start date
15 November 2015
Est. completion
31 December 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Progression-free survival (PFS); Overall survival (OS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov